Insidervault
Android app
LIVE FROM THE DATABASETRANSACTIONS 722,958COMPANIES 6,565LATEST TRADE Oct 26UPDATED Oct 27, 10:30 AM
Reporting ownerCIK 0001507174

Michael J. LaBarre

27 transactions in one company, from February 12, 2025 to February 27, 2025.

Transactions
271 company
Bought · P
$0open market
Sold · S
$1.3Mopen market
Net
−$1.3Mnet selling

By company

Where this insider traded.

CompanyTickerTradesBoughtSold
HALOZYME THERAPEUTICS, INC.HALO27—$1.3M

All transactions

27 in total, newest filings first.

CompanyTickerInsiderDateCodeSharesPriceValueHeld after
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 27SPLAN100$58.74$6K173,756
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 27SPLAN1,597$58.25$93K173,856
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 26SPLAN600$58.65$35K175,453
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 26SPLAN9,400$58.09$546K176,053
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 25SPLAN700$58.67$41K185,453
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 25SPLAN9,300$58.01$539K186,153
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefDERIVFeb 23MOption exercise4,747$0.00—?14,238derivatives
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 23FTax withholding2,410$57.75$139K195,453
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 23MOption exercise4,747$0.00—197,863
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefDERIVFeb 20AAward11,230$0.00—?11,230derivatives
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefDERIVFeb 20AAward11,902$0.00—?11,902derivatives
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefDERIVFeb 16MOption exercise4,263$0.00—?8,526derivatives
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefDERIVFeb 16MOption exercise6,112$0.00—?6,112derivatives
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefDERIVFeb 16MOption exercise20,891$0.00—?0derivatives
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefDERIVFeb 15MOption exercise3,386$0.00—?0derivatives
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 16FTax withholding2,164$58.29$126K193,116
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 16MOption exercise4,263$0.00—195,280
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 16FTax withholding3,103$58.29$181K191,017
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 16MOption exercise6,112$0.00—194,120
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 16FTax withholding8,721$58.29$508K188,008
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 16MOption exercise20,891$0.00—196,729
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 15FTax withholding1,304$58.29$76K175,838
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefFeb 15MOption exercise3,386$0.00—177,142
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefDERIVFeb 12AAward20,342$0.00—?20,342derivatives
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefDERIVFeb 12AAward4,921$0.00—?4,921derivatives
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefDERIVFeb 12AAward4,177$0.00—?6,547derivatives
HALOZYME THERAPEUTICS, INC.HALOMichael J. LaBarreChiefDERIVFeb 12AAward7,262$0.00—?20,891derivatives